Is DiaMedica Therapeutics Inc. (DMAC) a Buy, Sell, or Hold?
NASDAQ : DMAC
DiaMedica Therapeutics Inc.
$7.3 USD
$0.17 (2.38%)
- Volume
- 199.16K
- Average Volume
- 199.28K
- Market Capitalization
- $393.35M
- P/E Ratio
- -10.28
- Dividend Yield
- 0.00%
- Price Target
- $8.00
- Year High
- $10.42
- Year Low
- $3.88
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $9.11
Analyst Consensus Summary
Consensus Rating
Sell
6 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-8.8%
vs Current Price
Price Target
$8.00
Average TargetPrice Target Range
Lowest Target
$7.00
4.3% UPSIDE
Average Target
$8.00
Median Estimate
Highest Target
$10.00
-27.0% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 6
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 6 | 0 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Truist Financial | Bill Chappell | $10 | $4.4158 | 2024-10-07 05:07 AM | 126.5% |
| H.C. Wainwright | Matthew Caufield | $7 | $4.36 | 2024-10-07 02:05 AM | 60.6% |
| Craig-Hallum | Alex Nowak | $8 | $2.69 | 2024-03-21 05:10 AM | 197.4% |